On the other hand, Fernandez et al. reported significant associations between the rs6021191 variant of the NFATC2 gene and the development of AEs in patients with ALL who were being treated with L-Asp (Fernandez et al., 2015). This evidence concerns the gene NFATC2 and acute lymphoblastic leukemia.